Azala

Advances in Multiple Sclerosis Research-Series I

Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Is...

Deskribapen osoa

Gorde:
Formatua: Online
Hizkuntza:ingelesa
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2021
Gaiak:
multiple sclerosis
inflammation
oxidative
biomarker
sample size
autoimmune encephalitis
plasma exchange
autoimmunity
immunotherapeutics
clinical outcomes
major depression
bupropion
S-adenosylmethionine
vitamin D3
yoga
craniopharyngioma
fractionated stereotactic radiation treatments
sphenoid sinusitis
cranial nerve-VI palsy
autoimmune diseases
immune thrombocytopenic purpura
alemtuzumab
antibodies against GluR3 peptide
cognitive impairment
diagnosis
neuropsychological assessment
short intracortical inhibition
intracortical facilitation
fampridine
walking disability
TSPAN32
tetraspanins
cellular immunity
memory T cells
tDCS
neuroimaging
positron emission tomography
cerebral blood flow
probiotics
Streptococcus thermophilus
ST285
MBP83–99 peptide
mannan
immune modulation
agonist peptide
gut microbiome
gut–brain axis
metagenomics
disease-modifying treatments
MS
vaccine
immunomodulation
carriers
B cell receptor
delivery methods
immunotherapy
monoclonal antibodies
T cell receptor
tolerance
diagnostic markers
immunoglobulins
kappa
free light chains
antigen-specific immunotherapies
tolerogenic vaccines
tolerance induction
central nervous system
myelin peptides
myelin basic protei
proteolipid protein
myelin oligodendrocyte glycoprotein
nanotechnology
drug delivery nanosystems
lipids
polymers
vaccines
nanoparticles
antigen-specific immunotherapy
experimental autoimmune encephalomyelitis
neurodegeneration
chloroquine
EAE
dendritic cells
microglia
astrocytes
oligodendrocytes
conformational analysis
peptides
altered peptide ligands
NMR spectroscopy
NOE-constraints
molecular dynamic
trimolecular complex
Multiple Sclerosis
early-onset
adult-onset
Human Leucocyte Antigens
immunogenetics
clinical phenotype
clinical outcome
therapeutics
antibody detection
ELISA
multivalency
N-glucosylated peptide epitopes
peptide
conjugation
MOG35-55
Graphite/SiO2 electrode
voltammetry
HPLC
MS drugs
thema EDItEUR::M Medicine and Nursing
Sarrera elektronikoa:ONIX_20210501_9783039439478_329
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Gaia:Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the forefront of autoimmune research, in particular multiple sclerosis, for over 20 years. Delivery methods that are used to modulate effective and long-lasting immune responses have been the major focus. This Special Issue focused on delivery methods to be used for vaccines, immunotherapeutic approaches, drug design, and anti-inflammatories and their outcomes in preclinical studies and clinical trials.

Antzeko izenburuak